Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 233 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1K08CA241319-01
Utilization of molecular targeted radionuclides to prime immune responses at local and distant metastatic tumor sites
National Institutes of Health
Grant: 1DP5OD024576-01
Combining Radiation and Tumor-specific AntIbody Therapies to Elicit in Situ Tumor Vaccination
National Institutes of Health
Grant: U01CA233102
National Institutes of Health
Grant: P30 CA014520
National Institutes of Health
Grant: TL1TR002375
National Institutes of Health
Grant: T32 GM008692
National Institutes of Health
Grant: R35 CA197078
National Institutes of Health
Grant: U54CA232568
National Institutes of Health
Grant: T32CA009206
National Institutes of Health
Grant: P01CA250972
National Institutes of Health
Grant: NIH F30CA250263
National Institutes of Health
Grant: A UW 2020
National Institutes of Health
Grant: U54 HD090256
National Institutes of Health
Grant: RF1716
National Institutes of Health
Grant: 12805
National Institutes of Health
Grant: NM600
National Institutes of Health
Grant: F30CA250263
Wisconsin Alumni Research Foundation
Grant: UW2020
Benston Translational Research Fellowship
Grant: N/A
NIDCR NIH HHS
Grant: P50 DE026787
NIH HHS
Grant: DP5 OD024576
NCI NIH HHS
Grant: K08 CA241319
NCI NIH HHS
Grant: P30 CA047904
Midwest Atheletes Against Childhood Cancer
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Additional file 1 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Additional file 2 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Additional file 2 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Additional file 8 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 8 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 5 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 7 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 6 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 4 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 5 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 7 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 4 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 6 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 1 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 2 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 3 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 2 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 1 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity
Additional file 3 of BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity